ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 11 Issue 2, Summer 1997

June 13, 1997

Tighter Payment Policy

November 5, 2010

ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs

March 23, 1984

Straus asks to “Set Record Straight”

September 2, 1988

CCOP Applications Total 162; Three Committees, Headed By Ahmann, Loeb, Spur Will Review Them

November 19, 1982

Patch-Lozenge Combination Best For Smoking Cessation

November 27, 2009